<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04809922</url>
  </required_header>
  <id_info>
    <org_study_id>2020-02425; kt21Badertscher</org_study_id>
    <nct_id>NCT04809922</nct_id>
  </id_info>
  <brief_title>Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation</brief_title>
  <official_title>Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation in a Real-World Cohort of Patients; BASEL Wearable Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation (AF) is the most common cardiac arrhythmia. This study is to assess the&#xD;
      heart rhythm device accuracy of five cardiac wearable devices (Apple Watch, Kardia&#xD;
      Mobile/Kardia Mobile 6L, Fitbit Sense, Samsung Galaxy Watch 3 and Withings Scanwatch,&#xD;
      Withings SA, Model Number: HWA09) and its detection algorithms in identifying AF compared to&#xD;
      a nearly simultaneously acquired physician-interpreted 12-lead ECG in a real world cohort of&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 6, 2021</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rhythm device accuracy of cardiac wearable devices</measure>
    <time_frame>one time assessment at baseline</time_frame>
    <description>Heart rhythm device accuracy of five cardiac wearable devices (Apple Watch, Kardia Mobile/Kardia Mobile 6L, Fitbit Sense, Samsung Galaxy Watch 3 and Withings Scanwatch Withings SA, Model Number: HWA09) in detecting AF compared to nearly simultaneously acquired physician interpreted 12-lead ECG.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart rhythm device accuracy of physician-interpreted iECG</measure>
    <time_frame>one time assessment at baseline</time_frame>
    <description>Heart rhythm device accuracy of physician-interpreted iECG from a wearable device in detecting AF or SR compared to physician-interpreted 12-lead ECG</description>
  </primary_outcome>
  <enrollment type="Anticipated">334</enrollment>
  <condition>Atrial Fibrillation (AF)</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cardiac wearable devices</intervention_name>
    <description>five cardiac wearable devices&#xD;
Apple Watch, Apple Inc., Model Number: A1977 / A1978&#xD;
Kardia Mobile, AliveCor Inc., AC-009/Kardia Mobile 6L, AliveCor Inc., AC-019&#xD;
Fitbit Sense, Fitbit, Inc, Model Number: FB512&#xD;
Samsung Galaxy Watch 3 Samsung Inc., Model Number: SM-R855F&#xD;
Withings Scanwatch, Withings SA, Model Number: HWA09 Used for recording of one single-lead ECG. The results will be 274 compared to a simultaneous 12-lead ECG, which is considered the gold standard for detecting AF. There is no comparator in this trial.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing electrophysiological study, pacemaker or implantable defibrillator&#xD;
        (ICD) implantation or electric cardioversion at the University Hospital Basel.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All consecutive patients undergoing electrophysiological study, pacemaker or&#xD;
             implantable defibrillator (ICD) implantation or electric cardioversion at the&#xD;
             University Hospital Basel are eligible for study participation and will be asked to&#xD;
             participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of a radial artery graft for coronary artery bypass grafting&#xD;
&#xD;
          -  Tattoos located on the skin of the wrist or forearm where wearable device will be&#xD;
             placed&#xD;
&#xD;
          -  Patients receiving hemodialysis through arteriovenous fistula in the upper extremities&#xD;
&#xD;
          -  Patients with inability to communicate and comply with all study requirements&#xD;
&#xD;
          -  Patients who refused to participate in the trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Badertscher, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, University Hospital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick Badertscher, Dr. med.</last_name>
    <phone>+41-61-5565823</phone>
    <email>Patrick.badertscher@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diego Mannhart</last_name>
    <phone>+41 61 556 59 96</phone>
    <email>diego.mannhart@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Cardiology, University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Badertscher, Dr. med</last_name>
    </contact>
    <contact_backup>
      <last_name>Diego Mannhart</last_name>
      <phone>+41 61 556 59 96</phone>
      <email>diego.mannhart@usb.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Patrick Badertscher, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 18, 2021</study_first_submitted>
  <study_first_submitted_qc>March 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac Wearables Devices</keyword>
  <keyword>Sinus rhythm (SR)</keyword>
  <keyword>Lead-intelligent Electrocardiogram (iECG)</keyword>
  <keyword>heart rhythm device accuracy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

